
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
OneChain Immunotherapeutics is a spin-off Company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menendez
Biomedicina,carts,inmunoterapia,investigación,biotecnología,innovación,leucemia,hematología,and medicina personalizada
Onechain immunotherapeutics operates in the Biotechnology research industry.
Onechain immunotherapeutics's revenue is 11m - 100m
Onechain immunotherapeutics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.